Atomo Diagnostics Ltd logo

Atomo Diagnostics Ltd (AT1)

Market Open
ASX ASX
12.78M Market Cap
- P/E Ratio
- Div Yield
2.12M Volume
0 Eps
Want to track AT1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

AT1 is not paying dividends to its shareholders.
The last earnings report, released on Apr 23, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

Atomo Diagnostics Ltd (AT1) FAQ

On which exchange is it traded?

Atomo Diagnostics Ltd is listed on ASX.

What is its stock symbol?

The ticker symbol is AT1.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 12.78M.

Has Atomo Diagnostics Ltd ever had a stock split?

No, there has never been a stock split.

Atomo Diagnostics Ltd Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. John Michael Kelly CEO
ASX Exchange
Q0611N102 CUSIP
Australia Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Atomo Diagnostics Limited is a distinguished entity in the global medical devices market, specializing in the development and distribution of innovative diagnostic solutions. Founded in 2010 and based in Leichhardt, Australia, the company has carved a niche for itself by offering rapid diagnostic test devices that cater to a variety of healthcare needs. With a commitment to improving healthcare outcomes and accessibility, Atomo Diagnostics operates on a worldwide scale, reaching out to diverse markets to make diagnostic testing more reliable, simpler, and more user-friendly.

Products and Services

  • HIV Screening - Atomo Diagnostics provides rapid diagnostic test devices for HIV screening. These devices are designed to ensure high accuracy, ease of use, and rapid results, making them a crucial tool in the fight against the global HIV/AIDS pandemic. They are particularly valuable in regions where access to laboratory services is limited, enabling early detection and intervention.
  • Pregnancy Test - The company offers user-friendly and highly reliable pregnancy tests. These rapid diagnostic devices are celebrated for their precision and swift results. Ideal for home or clinical use, Atomo's pregnancy tests empower women with fast and accurate information regarding their pregnancy status, facilitating timely and informed decision-making.
  • Respiratory Test - Addressing the growing need for respiratory disease diagnostics, Atomo Diagnostics has developed rapid diagnostic tests that cater to this domain as well. These tests are vital in timely diagnosing and managing respiratory conditions, crucial in both routine healthcare settings and during respiratory disease outbreaks. Their reliability and rapid results support better patient outcomes through quicker therapeutic interventions.

Contact Information

Address: 3-5 George Street
Phone: 61 2 9099 4750